Related references
Note: Only part of the references are listed.EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
et al.
JOURNAL OF HEPATOLOGY (2015)
Gene polymorphisms of cellular senescence marker p21 and disease progression in non-alcohol-related fatty liver disease
Aloysious Aravinthan et al.
CELL CYCLE (2014)
Free Cholesterol Accumulation in Hepatic Stellate Cells: Mechanism of Liver Fibrosis Aggravation in Nonalcoholic Steatohepatitis in Mice
Kengo Tomita et al.
HEPATOLOGY (2014)
Association Between the PNPLA3 (rs738409 C>G) Variant and Hepatocellular Carcinoma: Evidence From a Meta-Analysis of Individual Participant Data
Eric Trepo et al.
HEPATOLOGY (2014)
Association of glucokinase regulatory gene polymorphisms with risk and severity of non-alcoholic fatty liver disease: an interaction study with adiponutrin gene
Hwa-Li Tan et al.
JOURNAL OF GASTROENTEROLOGY (2014)
Hepatocellular cancer: The impact of obesity, type 2 diabetes and a multidisciplinary team
Jessica Dyson et al.
JOURNAL OF HEPATOLOGY (2014)
Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma
Y. -L. Liu et al.
JOURNAL OF HEPATOLOGY (2014)
Systematic evaluation of coding variation identifies a candidate causal variant in TM6SF2 influencing total cholesterol and myocardial infarction risk
Oddgeir L. Holmen et al.
NATURE GENETICS (2014)
Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease
Julia Kozlitina et al.
NATURE GENETICS (2014)
Glucokinase Regulatory Protein Gene Polymorphism Affects Liver Fibrosis in Non-Alcoholic Fatty Liver Disease
Salvatore Petta et al.
PLOS ONE (2014)
Genetic Variation at NCAN Locus Is Associated with Inflammation and Fibrosis in Non-Alcoholic Fatty Liver Disease in Morbid Obesity
Alexis Gorden et al.
HUMAN HEREDITY (2013)
Non-alcoholic fatty liver disease: non-invasive investigation and risk stratification
J. K. Dyson et al.
JOURNAL OF CLINICAL PATHOLOGY (2013)
A CANDIDATE-GENE APPROACH TO VALIDATION OF GENETIC MODIFIER ASSOCIATIONS USING A LARGE COHORT WITH HISTOLOGICALLY CHARACTERISED NON-ALCOHOLIC FATTY LIVER DISEASE
Q. M. Anstee et al.
JOURNAL OF HEPATOLOGY (2013)
Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
Quentin M. Anstee et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
The global NAFLD epidemic
Rohit Loomba et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
The genetics of NAFLD
Quentin M. Anstee et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
The SOD2 C47T polymorphism influences NAFLD fibrosis severity: Evidence from case-control and intra-familial allele association studies
Ahmad Al-Serri et al.
JOURNAL OF HEPATOLOGY (2012)
Genetic Polymorphisms of the Human PNPLA3 Gene Are Strongly Associated with Severity of Non-Alcoholic Fatty Liver Disease in Japanese
Takahisa Kawaguchi et al.
PLOS ONE (2012)
Meta-analysis: Natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity
Giovanni Musso et al.
ANNALS OF MEDICINE (2011)
Genome-Wide Association Studies: Results from the First Few Years and Potential Implications for Clinical Medicine
Joel N. Hirschhorn et al.
ANNUAL REVIEW OF MEDICINE, VOL 62, 2011 (2011)
Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma
John C. Chambers et al.
NATURE GENETICS (2011)
Genome-Wide Association Analysis Identifies Variants Associated with Nonalcoholic Fatty Liver Disease That Have Distinct Effects on Metabolic Traits
Elizabeth K. Speliotes et al.
PLOS GENETICS (2011)
Genetic variants regulating insulin receptor signalling are associated with the severity of liver damage in patients with non-alcoholic fatty liver disease
P. Dongiovanni et al.
GUT (2010)
I148M Patatin-Like Phospholipase Domain-Containing 3 Gene Variant and Severity of Pediatric Nonalcoholic Fatty Liver Disease
Luca Valenti et al.
HEPATOLOGY (2010)
Homozygosity for the Patatin-Like Phospholipase-3/Adiponutrin I148M Polymorphism Influences Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease
Luca Valenti et al.
HEPATOLOGY (2010)
Biological, clinical and population relevance of 95 loci for blood lipids
Tanya M. Teslovich et al.
NATURE (2010)
Magnetic resonance imaging and spectroscopy accurately estimate the severity of steatosis provided the stage of fibrosis is considered
Stuart McPherson et al.
JOURNAL OF HEPATOLOGY (2009)
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Stefano Romeo et al.
NATURE GENETICS (2008)
Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans
Sekar Kathiresan et al.
NATURE GENETICS (2008)
Genetic Mapping in Human Disease
David Altshuler et al.
SCIENCE (2008)
PLINK: A tool set for whole-genome association and population-based linkage analyses
Shaun Purcell et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2007)
Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis
Kanji Yamaguchi et al.
HEPATOLOGY (2007)
Long-term follow-up of patients with NAFLD and elevated liver enzymes
Mattias Ekstedt et al.
HEPATOLOGY (2006)
The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves' disease
MR Velaga et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits
S Purcell et al.
BIOINFORMATICS (2003)
Cloning of the novel gene TM6SF1 reveals conservation of clusters of paralogous genes be tween human chromosomes 15q24 -> q26 and 19p13.3 -> p12
L Carim-Todd et al.
CYTOGENETICS AND CELL GENETICS (2000)